160 related articles for article (PubMed ID: 30635982)
1. Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer.
Xu C; Wang Y; Yuan Q; Wang W; Chi C; Zhang Q; Zhang X
J Cell Mol Med; 2019 Mar; 23(3):2077-2082. PubMed ID: 30635982
[TBL] [Abstract][Full Text] [Related]
2. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
Du ZY; Shi MH; Ji CH; Yu Y
Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
Molina R; Augé JM; Bosch X; Escudero JM; Viñolas N; Marrades R; Ramírez J; Carcereny E; Filella X
Tumour Biol; 2009; 30(3):121-9. PubMed ID: 19506400
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the diagnostic and prognostic value of serum TuM2-PK, NSE, and ProGRP in small cell lung cancer.
Li L; Zhang Q; Wang Y; Xu C
J Clin Lab Anal; 2023 Apr; 37(7):e24865. PubMed ID: 37088873
[TBL] [Abstract][Full Text] [Related]
6. Pleiotrophin as a potential biomarker in breast cancer patients.
Ma J; Kong Y; Nan H; Qu S; Fu X; Jiang L; Wang W; Guo H; Zhao S; He J; Nan K
Clin Chim Acta; 2017 Mar; 466():6-12. PubMed ID: 28041942
[TBL] [Abstract][Full Text] [Related]
7. Plasma proGRP concentration is sensitive and specific for discriminating small cell lung cancer from nonmalignant conditions or non-small cell lung cancer.
Kim HR; Oh IJ; Shin MG; Park JS; Choi HJ; Ban HJ; Kim KS; Kim YC; Shin JH; Ryang DW; Suh SP
J Korean Med Sci; 2011 May; 26(5):625-30. PubMed ID: 21532852
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of serum vascular endothelial growth factor and Angiopoietin-2 in patients with lung cancer.
Akın Kabalak P; Çiledağ A; Demir N; Çelik G; Yüksel C; Köycü G; Gökmen Öztuna D; Taner A; Kaya A; Kutlay H; Numanoğlu N; Savaş İ
Tuberk Toraks; 2015 Jun; 63(2):71-7. PubMed ID: 26167963
[TBL] [Abstract][Full Text] [Related]
9. Expression of pleiotrophin in small cell lung cancer.
Wang HQ; Wang J
J Biol Regul Homeost Agents; 2015; 29(1):175-9. PubMed ID: 25864755
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications for pro-GRP in small cell lung cancer. A single center experience.
Cavalieri S; Morelli D; Martinetti A; Galli G; Nichetti F; de Braud F; Platania M
Int J Biol Markers; 2018 Jan; 33(1):55-61. PubMed ID: 28967066
[TBL] [Abstract][Full Text] [Related]
11. Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients.
Yang DW; Zhang Y; Hong QY; Hu J; Li C; Pan BS; Wang Q; Ding FH; Ou JX; Liu FL; Zhang D; Zhou JB; Song YL; Bai CX
Cancer; 2015 Sep; 121 Suppl 17():3113-21. PubMed ID: 26331818
[TBL] [Abstract][Full Text] [Related]
12. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
[TBL] [Abstract][Full Text] [Related]
13. Pleiotrophin serum level and metastasis occurrence in breast cancer patients.
Ikhlas M; Ferianto D; Syamsu SA; Ganda IJ; Smaradania N; Sampepajung E; Anggita CA; Faruk M
Breast Dis; 2024; 43(1):93-98. PubMed ID: 38701136
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.
Zhang C; Jia Y; Jia Y; Zhang X; Li K
Int J Clin Oncol; 2018 Dec; 23(6):1070-1075. PubMed ID: 30168089
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer.
Xu CH; Yu LK; Hao KK
PLoS One; 2014; 9(5):e96384. PubMed ID: 24801872
[TBL] [Abstract][Full Text] [Related]
16. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
Shen D; Han BB; Chen F; Wei BJ; Cui CJ; Wang GJ; Cui W
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2657-2662. PubMed ID: 28910952
[No Abstract] [Full Text] [Related]
17. Serum Heat Shock Protein 70, as a Potential Biomarker for Small Cell Lung Cancer.
Balázs M; Zsolt H; László G; Gabriella G; Lilla T; Gyula O; Balázs D; Éva M; Zoltán B; Zoltán P; Judit K
Pathol Oncol Res; 2017 Apr; 23(2):377-383. PubMed ID: 27704355
[TBL] [Abstract][Full Text] [Related]
18. Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients.
Karapanagiotou EM; Terpos E; Dilana KD; Alamara C; Gkiozos I; Polyzos A; Syrigos KN
Med Oncol; 2010 Jun; 27(2):332-8. PubMed ID: 19373566
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic value of ProGRP in lung cancer.
Nisman B; Biran H; Ramu N; Heching N; Barak V; Peretz T
Anticancer Res; 2009 Nov; 29(11):4827-32. PubMed ID: 20032442
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of serum cytokines in small cell lung cancer and its clinical significance].
Lu X; Yang X; Yang Y; Gu X; Liao L; Wang D
Zhongguo Fei Ai Za Zhi; 2012 Jan; 15(1):11-6. PubMed ID: 22237118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
